Evaluating the practice of cholecystectomy during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
Journal of Gastrointestinal Surgery Open · 2026
DOI: 10.1016/j.jogsop.2026.100032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastrointestinal Surgery Open, 2026. Verfasst von Oscar Hernandez Dominguez und 7 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has been shown to increase survival in select patients with peritoneal metastasis. One point of contention is whether a cholecystectomy should be performed during the index CRS/HIPEC as this may avoid the risk of missing difficult-to-assess gallbladder (GB) tumor involvement and the potential for a higher-risk cholecystectomy in a post-CRS/HIPEC abdomen. We aim to evaluate the practice of cholecystectomy during CRS/HIPEC and analyze the outcomes of concurrent cholecystectomy.
Methods
Adult patients who underwent CRS with HIPEC across our quaternary care health center were retrospectively reviewed for GB disease pre- or post-CRS/HIPEC or GB intervention at index or post-CRS/HIPEC. Patients with prior cholecystectomy were excluded. Pre-operative variables collected included patient demographics, cancer diagnosis, and surgical history. Operative reports were reviewed for intraoperative GB evaluation, GB interventions, peritoneal cancer index (PCI), and surgeon specialty. Post-CRS/HIPEC GB disease, GB intervention, and associated complications, and mortality were collected. Cholecystectomy pathology reports were reviewed for GB disease and malignant involvement.
Results
Between 2009 and 2023, a total of 83 patients underwent CRS with HIPEC and met our inclusion criteria (Table 1). 64 patients underwent cholecystectomy at index CRS/HIPEC, with one Clavien-Dindo (CD) grade-I complication. Post-CRS/HIPEC GB intervention was required for 11 out of the 19 remaining patients (58%) which included 8 open cholecystectomies, 1 cholecystostomy tube, and 1 medical-management with 1 CD-IV complication during cholecystectomy. Two of the patients who required open cholecystectomy had preoperative evidence of cholelithiasis. Among the 64 patients who underwent concurrent cholecystectomy and CRS/HIPEC, 28 patients had evidence of malignant gallbladder involvement. Only 12 out of 20 patients with preoperative evidence of gall bladder disease underwent cholecystectomy at time of CRS/HIPEC. Cholelithiasis was the most common preoperative gall bladder disease. The concordance between intra-operative surgeon perspective of GB disease and final pathology was 56%. Patients who underwent cholecystectomy had a lower PCI compared to those who didn't (p-value 0.014).
Conclusion
In our study, cholecystectomy performed during CRS/HIPEC has demonstrated minimal complications. Furthermore, cholecystectomy at time of CRS/HIPEC may ensure a more comprehensive removal of cancerous tissue. Cholecystectomy at the time of CRS/HIPEC may decrease the need for further interventions in this complex patient population.
Zitieren
APA
Dominguez, O. H., Moussally, M., Gorgun, E., Wilkens, E., Liska, D., Steele, S. R., Joyce, D., & Valente, M. (2026). Evaluating the practice of cholecystectomy during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Journal of Gastrointestinal Surgery Open. https://doi.org/10.1016/j.jogsop.2026.100032
Vancouver
Dominguez OH, Moussally M, Gorgun E, Wilkens E, Liska D, Steele SR, et al. Evaluating the practice of cholecystectomy during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Journal of Gastrointestinal Surgery Open. 2026. doi:10.1016/j.jogsop.2026.100032
BibTeX
@article{Dominguez2026,
author = {Dominguez, Oscar Hernandez and Moussally, Moustafa and Gorgun, Emre and Wilkens, Eric and Liska, David and Steele, Scott R. and Joyce, Daniel and Valente, Michael},
title = {Evaluating the practice of cholecystectomy during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy},
journal = {Journal of Gastrointestinal Surgery Open},
year = {2026},
doi = {10.1016/j.jogsop.2026.100032}
}
EUVIMED